Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.

Announcements

503

Total raised

£3.8B

disclosed amounts

This month

£36.9M

raised so far

Series B
£2.1M

The oversubscribed EIS round will fund team expansion and international growth.

"It has been a pleasure to work with Gayle and her supportive team, and the success of our collaboration has been well illustrated with an oversubscribed investment round. Raising investment in today’s markets, for Companies at a similar stage in their development and investment cycle, is extremely difficult. Having the backing of Wealth Club and our existing investors provides the Company with a great deal of confidence, as we head into our growth stage. The success of this round will provide working capital for the Company to invest in revenue growth across our sectors, in addition to investing in our technology and platforms to scale and service our existing clients and an already healthy new business pipeline."
— Richard Freeman, Founder and Chief Executive
Other
£4.7M

The financing round was led by SCVC with participation from a group of institutional investors and agencies.

"Essentially, our technology generates very small droplets which are ideal for peripheral inhalation drug delivery, and also the potential for systemic drug delivery through the inhalation route rather than via injection."
— Elijah Nazarzadeh
Series B
£17.0M

The financing round was backed by Bayland Capital and founding shareholder CN Innovations to accelerate product development and commercial expansion.

"We are seeing pivotal growth across our industry, whereby drug developers are increasingly recognising the potential of OOC technology to augment, supplement and optimize their workflows."
— Paul Brooks, CEO
Seed
£1.1M

Aviva Ventures led the seed financing round for the London-based healthtech firm, with participation from Ascension, Oxford Capital, and Cur8 Capital.

"So far, we’ve been driven by a singular mission to unlock and simplify access to everything you need to live a healthier life, which requires a shift in how health and well-being services are provided and paid for, and means putting the user in the driver seat and giving them more control. By creating an integrated network of health providers and payers, we can improve access to personalised health services, particularly in traditionally underfunded and underserved areas, such as early diagnosis, women’s health, mental health and neurodiversity."
— David Joerring, Co-Founder and CEO